Main neuroendocrine features, diagnosis and therapeutic possibilities in the chronic fatigue syndrome, an underdiagnosed entity.
Amihăesei, Ioana Cristina, Cojocaru, Elena · Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi · 2014
Quick Summary
ME/CFS is a serious illness marked by extreme tiredness that doesn't improve with rest, along with problems concentrating, pain, and worsening symptoms after activity. Diagnosis requires at least six months of severe fatigue plus four or more other specific symptoms. Current treatments focus on behavioral approaches and pacing rather than medications, though only about 5% of people fully recover, and more than half become unable to work.
Why It Matters
This study helps validate ME/CFS as a distinct medical entity with objective diagnostic criteria, countering the historical dismissal of the condition. Understanding the established diagnostic framework and documented treatment approaches supports both patient recognition and clinical management discussions. The emphasis on severe occupational disability highlights the urgent need for better understanding and treatment options.
Observed Findings
Diagnosis requires six months of severe fatigue plus four or more associated symptoms including concentration/memory problems, pain, post-exertional exhaustion, and mood disturbances.
More than 50% of ME/CFS patients are unable to work due to disease severity.
Average full recovery rate is approximately 5%.
Common symptoms include irritable bowel syndrome-like features, depression, anxiety, and panic attacks.
Cognitive behavioral therapy and graded exercise therapy are standard management approaches, with medications playing a minor role.
Inferred Conclusions
ME/CFS is a severe, underdiagnosed condition requiring clinical recognition and appropriate diagnostic criteria.
Current management relies primarily on behavioral and pacing strategies rather than pharmacological interventions.
The etiology remains unclear, limiting the development of targeted treatments.
The disease has substantial impact on patient functioning and occupational capacity.
Remaining Questions
What are the underlying neuroendocrine mechanisms driving ME/CFS symptoms?
What This Study Does Not Prove
This review does not establish the underlying biological mechanisms or confirm causative factors, as the authors acknowledge that post-viral and stress hypotheses remain unverified. The study does not provide evidence comparing the efficacy of different treatment approaches, nor does it explain why recovery rates are so low. It also does not identify new diagnostic biomarkers or propose novel therapeutic interventions.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.